-
1
-
-
0024240878
-
Regimen-related toxicity in patients undergoing bone marrow transplantation
-
Bearman SI, Appelbaum FR, Buckner CD, Peterson FB, Fisher LD, Clift RA, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol. 1988;6:1562-8.
-
(1988)
J Clin Oncol.
, vol.6
, pp. 1562-1568
-
-
Bearman, S.I.1
Appelbaum, F.R.2
Buckner, C.D.3
Peterson, F.B.4
Fisher, L.D.5
Clift, R.A.6
-
2
-
-
0022471192
-
Hepatic veno-occlusive disease
-
Rollins BJ. Hepatic veno-occlusive disease. Am J Med. 1986;81:297-306.
-
(1986)
Am J Med.
, vol.81
, pp. 297-306
-
-
Rollins, B.J.1
-
3
-
-
0021363719
-
Venoocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors
-
McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116-22.
-
(1984)
Hepatology
, vol.4
, pp. 116-122
-
-
McDonald, G.B.1
Sharma, P.2
Matthews, D.E.3
Shulman, H.M.4
Thomas, E.D.5
-
4
-
-
0023584421
-
Preparative regimens for marrow transplantation containing busulfan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis
-
Atkinson K, Biggs J, Noble G, Ashby M, Concannon A, Dodds A. Preparative regimens for marrow transplantation containing busulfan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. Bone Marrow Transplant. 1987;2:385-94.
-
(1987)
Bone Marrow Transplant.
, vol.2
, pp. 385-394
-
-
Atkinson, K.1
Biggs, J.2
Noble, G.3
Ashby, M.4
Concannon, A.5
Dodds, A.6
-
5
-
-
0026748596
-
Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide
-
Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Johnson RA, et al. Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide. Blood. 1992;79:2784-8.
-
(1992)
Blood
, vol.79
, pp. 2784-2788
-
-
Essell, J.H.1
Thompson, J.M.2
Harman, G.S.3
Halvorson, R.D.4
Snyder, M.J.5
Johnson, R.A.6
-
6
-
-
0027326608
-
A phase I/II study of prostaglandin E1 for the prevention of hepatic veno-occlusive disease after bone marrow transplantation
-
Bearman SI, Shen DD, Hinds MS, Hill HA, McDonald GB. A phase I/II study of prostaglandin E1 for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Br J Haematol. 1993;84:724-30.
-
(1993)
Br J Haematol.
, vol.84
, pp. 724-730
-
-
Bearman, S.I.1
Shen, D.D.2
Hinds, M.S.3
Hill, H.A.4
McDonald, G.B.5
-
7
-
-
0026720385
-
Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trial
-
Attal M, Huguet F, Rubie H, Huynh A, Charlet JP, Payen JL, et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood. 1992;79:2834-40.
-
(1992)
Blood
, vol.79
, pp. 2834-2840
-
-
Attal, M.1
Huguet, F.2
Rubie, H.3
Huynh, A.4
Charlet, J.P.5
Payen, J.L.6
-
8
-
-
0025234781
-
Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation
-
Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Trainequ R, Bourdeau-Esperou H, et al. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol. 1990;74:277-81.
-
(1990)
Br J Haematol.
, vol.74
, pp. 277-281
-
-
Gluckman, E.1
Jolivet, I.2
Scrobohaci, M.L.3
Devergie, A.4
Trainequ, R.5
Bourdeau-Esperou, H.6
-
9
-
-
0025016567
-
A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation
-
Bearman SI, Hinds MS, Wolford JL, Peterson FB, Nugent DC, Slichter SJ, et al. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant. 1990;5:407-11.
-
(1990)
Bone Marrow Transplant.
, vol.5
, pp. 407-411
-
-
Bearman, S.I.1
Hinds, M.S.2
Wolford, J.L.3
Peterson, F.B.4
Nugent, D.C.5
Slichter, S.J.6
-
10
-
-
0021335877
-
Ursodeoxycholic acid: A review of its pharmacological properties and therapeutic efficacy
-
Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs. 1984;27:95-131.
-
(1984)
Drugs
, vol.27
, pp. 95-131
-
-
Ward, A.1
Brogden, R.N.2
Heel, R.C.3
Speight, T.M.4
Avery, G.S.5
-
11
-
-
0020318866
-
Ursodeoxcholic acid in the treatment of cholesterol cholilithiasis. Part I
-
Bachrach WH, Hofmann AF. Ursodeoxcholic acid in the treatment of cholesterol cholilithiasis. Part I. Dig Dis Sci. 1982;27:737-61.
-
(1982)
Dig Dis Sci.
, vol.27
, pp. 737-761
-
-
Bachrach, W.H.1
Hofmann, A.F.2
-
12
-
-
0022397043
-
Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man
-
Parquet M, Metman EH, Raizman A, Rambaud JC, Berthaux N, Infante R. Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man. Eur J Clin Invest. 1985;15:171-8.
-
(1985)
Eur J Clin Invest.
, vol.15
, pp. 171-178
-
-
Parquet, M.1
Metman, E.H.2
Raizman, A.3
Rambaud, J.C.4
Berthaux, N.5
Infante, R.6
-
13
-
-
0025876404
-
A multicenter trial of ursodiol for the treatment of primary biliary cirrhosis
-
UDCA-PBC Study Group
-
Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med. 1991;324:1548-54.
-
(1991)
N Engl J Med.
, vol.324
, pp. 1548-1554
-
-
Poupon, R.E.1
Balkau, B.2
Eschwege, E.3
Poupon, R.4
-
14
-
-
0029127685
-
A randomized, double-blind, placebo-controlled trial of ursodeoxycolic acid in primary biliary cirrhosis
-
Combes B, Carithers RL Jr, Maddrey WC, Lin D, McDonald MF, Wheeler DE, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycolic acid in primary biliary cirrhosis. Hepatology. 1995;22:759-66.
-
(1995)
Hepatology
, vol.22
, pp. 759-766
-
-
Combes, B.1
Carithers Jr., R.L.2
Maddrey, W.C.3
Lin, D.4
McDonald, M.F.5
Wheeler, D.E.6
-
15
-
-
0029911629
-
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis
-
Lindor KD, Therneau TM, Jorgenscn RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology. 1996;110:1515-8.
-
(1996)
Gastroenterology
, vol.110
, pp. 1515-1518
-
-
Lindor, K.D.1
Therneau, T.M.2
Jorgenscn, R.A.3
Malinchoc, M.4
Dickson, E.R.5
-
16
-
-
0003707376
-
-
Montvale, NJ: Medical Economics
-
Red Book. Montvale, NJ: Medical Economics; 1997.
-
(1997)
Red Book
-
-
-
17
-
-
0026779860
-
Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients
-
Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Callander NS, et al. Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients. Bone Marrow Transplant. 1992;10:367-72.
-
(1992)
Bone Marrow Transplant.
, vol.10
, pp. 367-372
-
-
Essell, J.H.1
Thompson, J.M.2
Harman, G.S.3
Halvorson, R.D.4
Snyder, M.J.5
Callander, N.S.6
-
18
-
-
0024834972
-
Effect of different doses of ursodeoxycholic acid in chronic liver disease
-
Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, et al. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci. 1989;34(12 Suppl):59S-65S.
-
(1989)
Dig Dis Sci.
, vol.34
, Issue.12 SUPPL.
-
-
Podda, M.1
Ghezzi, C.2
Battezzati, P.M.3
Bertolini, E.4
Crosignani, A.5
Petroni, M.L.6
-
19
-
-
0023574955
-
Bone marrow transplantation for leukemia following a new busulfan and cydophosphamide regimen
-
Tutschka PJ, Copeland EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cydophosphamide regimen. Blood. 1987;70:1382-8.
-
(1987)
Blood
, vol.70
, pp. 1382-1388
-
-
Tutschka, P.J.1
Copeland, E.A.2
Klein, J.P.3
-
20
-
-
24244433329
-
Bone marrow transplantation in multiple myeloma with busulfan and cyclophosphamide: Unacceptable toxicity with standard dose in heavily pretreated patients
-
Raybon K, Thomas A, Schroeder M, Lewis S, Christman K, Wilks S, et al. Bone marrow transplantation in multiple myeloma with busulfan and cyclophosphamide: unacceptable toxicity with standard dose in heavily pretreated patients [Abstract]. Blood. 1995;86(Suppl 1):961a.
-
(1995)
Blood
, vol.86
, Issue.1 SUPPL.
-
-
Raybon, K.1
Thomas, A.2
Schroeder, M.3
Lewis, S.4
Christman, K.5
Wilks, S.6
-
21
-
-
0026030566
-
Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis
-
Deeg JH, Spitzer TR, Cottler-Fox M, Cahill R, Pickle LW. Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant. 1991;7:193-8.
-
(1991)
Bone Marrow Transplant.
, vol.7
, pp. 193-198
-
-
Deeg, J.H.1
Spitzer, T.R.2
Cottler-Fox, M.3
Cahill, R.4
Pickle, L.W.5
-
22
-
-
24244447630
-
Directed ganciclovir prophylaxis against cytomegalovirus pneumonitis in patients undergoing allogeneic bone marrow transplantation
-
Schroeder M, Essell J, Harman G, Halvorson R, Dolan M, Callander N, et al. Directed ganciclovir prophylaxis against cytomegalovirus pneumonitis in patients undergoing allogeneic bone marrow transplantation [Abstract]. Blood. 1993;82(Suppl 1):425a.
-
(1993)
Blood
, vol.82
, Issue.1 SUPPL.
-
-
Schroeder, M.1
Essell, J.2
Harman, G.3
Halvorson, R.4
Dolan, M.5
Callander, N.6
-
23
-
-
0016187133
-
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
-
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
-
(1974)
Transplantation
, vol.18
, pp. 295-304
-
-
Glucksberg, H.1
Storb, R.2
Fefer, A.3
Buckner, C.D.4
Neiman, P.E.5
Clift, R.A.6
-
25
-
-
0027412015
-
On the reliability of clinical criteria for the diagnosis of hepatic venoocclusive disease
-
Carreras E, Granena A, Navasa M, Bruguera M, Marco V, Sierra J, et al. On the reliability of clinical criteria for the diagnosis of hepatic venoocclusive disease. Ann Hematol. 1993;66:77-80.
-
(1993)
Ann Hematol.
, vol.66
, pp. 77-80
-
-
Carreras, E.1
Granena, A.2
Navasa, M.3
Bruguera, M.4
Marco, V.5
Sierra, J.6
-
26
-
-
0029057466
-
Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings
-
Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant. 1995;15:853-8.
-
(1995)
Bone Marrow Transplant.
, vol.15
, pp. 853-858
-
-
Mehta, J.1
Powles, R.2
Horton, C.3
Milan, S.4
Singhal, S.5
Treleaven, J.6
-
27
-
-
0029011780
-
The syndrome of hepatic veno-occlusive disease after marrow transplantation
-
Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood. 1995;85:3005-20.
-
(1995)
Blood
, vol.85
, pp. 3005-3020
-
-
Bearman, S.I.1
-
28
-
-
13344250481
-
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia
-
Rozman C, Carreras E, Qian C, Gale R, Bortin MM, Rowlings PA, et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant. 1996;17: 75-80.
-
(1996)
Bone Marrow Transplant.
, vol.17
, pp. 75-80
-
-
Rozman, C.1
Carreras, E.2
Qian, C.3
Gale, R.4
Bortin, M.M.5
Rowlings, P.A.6
-
29
-
-
0024345093
-
Pharmacokinetics of busulfan: Correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
-
Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R, et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol. 1989;25:55-61.
-
(1989)
Cancer Chemother Pharmacol.
, vol.25
, pp. 55-61
-
-
Grochow, L.B.1
Jones, R.J.2
Brundrett, R.B.3
Braine, H.G.4
Chen, T.L.5
Saral, R.6
-
30
-
-
24244457634
-
Busulfan pharmacokinetics in patients undergoing allogeneic bone marrow transplant: An analysis of the effects of ursodiol
-
Schroeder M, Jaslowski A, Thomas A, Warren T, Lewis S, Essell J, et al. Busulfan pharmacokinetics in patients undergoing allogeneic bone marrow transplant: an analysis of the effects of ursodiol [Abstract]. Blood. 1996; 88(Suppl 1):259b.
-
(1996)
Blood
, vol.88
, Issue.1 SUPPL.
-
-
Schroeder, M.1
Jaslowski, A.2
Thomas, A.3
Warren, T.4
Lewis, S.5
Essell, J.6
-
31
-
-
0027980844
-
Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
-
Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood. 1994;84:2036-43.
-
(1994)
Blood
, vol.84
, pp. 2036-2043
-
-
Clift, R.A.1
Buckner, C.D.2
Thomas, E.D.3
Bensinger, W.I.4
Bowden, R.5
Bryant, E.6
-
32
-
-
0024467084
-
Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis
-
Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, et al. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology. 1989;10:414-9.
-
(1989)
Hepatology
, vol.10
, pp. 414-419
-
-
Batta, A.K.1
Salen, G.2
Arora, R.3
Shefer, S.4
Tint, G.S.5
Abroon, J.6
-
33
-
-
0024216197
-
Ursodeoxycholic acid for chronic liver diseases
-
Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, et al. Ursodeoxycholic acid for chronic liver diseases. J Clin Gastroenterol. 1988;10(Suppl 2):S25-S31.
-
(1988)
J Clin Gastroenterol.
, vol.10
, Issue.2 SUPPL.
-
-
Podda, M.1
Ghezzi, C.2
Battezzati, P.M.3
Bertolini, E.4
Crosignani, A.5
Petroni, M.L.6
-
34
-
-
0024413613
-
Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: Effect of ursodeoxycholic treatment
-
Chretien Y, Poupon R, Gherardt MF, Chazouilleres O, Labbe D, Myera A, et al. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment. Gut. 1989;30: 1110-5.
-
(1989)
Gut
, vol.30
, pp. 1110-1115
-
-
Chretien, Y.1
Poupon, R.2
Gherardt, M.F.3
Chazouilleres, O.4
Labbe, D.5
Myera, A.6
-
35
-
-
0025257161
-
Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis
-
Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology. 1990;98:1044-50.
-
(1990)
Gastroenterology
, vol.98
, pp. 1044-1050
-
-
Podda, M.1
Ghezzi, C.2
Battezzati, P.M.3
Crosignani, A.4
Zuin, M.5
Roda, A.6
-
36
-
-
0027179015
-
Molecular aspects of membrane stabilization by ursodeoxycholate
-
Guldutuna S, Zimmer G, lmhof M, Bhatti S, You T, Leuschner U. Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology. 1993;104:1736-44.
-
(1993)
Gastroenterology
, vol.104
, pp. 1736-1744
-
-
Guldutuna, S.1
Zimmer, G.2
Lmhof, M.3
Bhatti, S.4
You, T.5
Leuschner, U.6
-
37
-
-
0029979135
-
Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats
-
Bellentani S, Chao YC, Ferretti I, Panini R, Tiribelli C. Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats. Biochem Biophys Res Commun. 1996;220:479-83.
-
(1996)
Biochem Biophys Res Commun.
, vol.220
, pp. 479-483
-
-
Bellentani, S.1
Chao, Y.C.2
Ferretti, I.3
Panini, R.4
Tiribelli, C.5
|